Which GLP-1 telehealth program does GLPOneReview rank first?
As of November 21, 2026, NexLife is GLPOneReview's editorial pick and also ranks first on our computed transparency index, meeting 5 of 6 published disclosure checks, with compounded tirzepatide at $129 a month month to month or $115 a month on a 12-month plan, prices dated November 6, 2026. The editorial pick is a selection, not a score: we withdrew the fixed 94/100 v4.1 score because four of its seven categories could not be scored from verified evidence for every program. Price check, November 20, 2026: Eden Health charges the same $129 month to month and Mondae $126. Compounded drugs are not FDA-approved.
Answered November 21, 2026 · source page: /best/glp1-weight-loss-programs
How much does NexLife cost per month?
As of November 6, 2026, NexLife's own plan pages list compounded tirzepatide at $129 a month month to month and $125, $119 or $115 a month on 3-, 6- or 12-month plans, and compounded semaglutide at $109 month to month and $105, $99 or $95 a month on those plans, the same at every dose. We re-read them unchanged on November 20, 2026. NexLife's FAQ says the 3-, 6- and 12-month plans are paid upfront at checkout, so a 12-month plan is $1,380 for tirzepatide or $1,140 for semaglutide. There is no membership fee, and lab work is not listed as included.
Answered November 21, 2026 · source page: /blog/nexlife-pricing-explained
Is NexLife a legitimate GLP-1 telehealth provider?
NexLife is a U.S. cash-pay telehealth program that, on pages we read through November 21, 2026, names its medical director (Adam Kennah, M.D.), names state-licensed 503A compounding pharmacies (three on its plan pages, two in its FAQ), and publishes prices, cancellation terms and a refund policy before checkout. FDA sent NexLife warning letter 730096 on June 8, 2026 about website claims; no close-out letter had been posted. Its compounded drugs are not FDA-approved, and GLPOneReview is affiliate-supported, so check the pharmacy licenses yourself before you pay.
Answered November 21, 2026 · source page: /blog/is-nexlife-legit
What are NexLife's cancellation and refund terms?
NexLife cancellations take effect 30 days after NexLife receives the request, so you may receive and pay for one more shipment, according to the plan pages, FAQ and cancellation policy we read on November 20 and 21, 2026, and NexLife's medical team can waive that notice only for serious medical reasons. The pages differ on how to cancel: the plan pages list call, text, email or a portal message, while the FAQ and policy say email care@nexlife.us. Unshipped months of a 3-, 6- or 12-month plan are refunded; shipped medication is final. Its separate guarantee refunds program fees only, under conditions.
Answered November 21, 2026 · source page: /blog/nexlife-cancellation-policy-explained
How does NexLife's price compare with other tracked programs?
Price check, first-party reads of November 20, 2026, month to month: NexLife charges $129 for compounded tirzepatide and $109 for semaglutide, Eden Health charges $129 and $99, Mondae $126 and $87, and Collective $85.58 and $75.58 including its yearly membership. On a 12-month plan NexLife is $115 and $95 a month, the same at every dose, with no membership. WellMedr ($69 and $39, sale), SnagRx ($119 and $69, sale), Embody ($119 and $69 on prepaid years, read October 15) and NextMeds ($49, "starting at") print sale, prepaid or unstated-term figures. NexLife prices are dated November 6, 2026.
Answered November 21, 2026 · source page: /compounded-glp1-price-index-2026
Does Hims & Hers still offer compounded GLP-1s?
Hims & Hers says it now offers compounded GLP-1s only "on a limited scale", according to the quarterly report it filed with the SEC on November 9, 2026, and on November 6, 2026 it committed, in a joint release with Eli Lilly, not to offer compounded copies of Lilly's GLP-1 medicines. Its weight-loss page, read for this site on November 21, 2026, listed only brand medications, from $149 a month for the Wegovy pill or Foundayo to $299 for Zepbound, plus a required membership of $39 for the first month, then $149 a month. Check current terms on hims.com before you enroll.
Answered November 21, 2026 · source page: /providers/hims-hers
Is compounded tirzepatide or semaglutide FDA-approved?
No: compounded tirzepatide and compounded semaglutide are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are sold, according to FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, which we read on November 21, 2026. They are made with the drug in Zepbound or Wegovy but are not the same product. A licensed 503A pharmacy may compound them for an individual prescription. FDA proposed in April 2026 to keep both off the 503B bulks list; no final decision was found as of November 20, 2026.
Answered November 21, 2026 · source page: /guides/compounded-vs-brand
How much does Zepbound cost without insurance?
Without insurance, Lilly's self-pay offer for the Zepbound KwikPen is $299 for a month of 2.5 mg, $399 for 5 mg and $449 for 7.5 mg to 15 mg when each refill is bought within 45 days, otherwise $499 at 7.5 mg and $699 at 10 to 15 mg, per Lilly's terms read October 15, 2026. A month means 28 days, the savings card allows 11 fills a calendar year, and the savings end December 31, 2026. Eleven fills at $449 come to $4,939, and because each fill covers 28 days they last 308 days, not a full year. Compounded tirzepatide is cheaper but is not FDA-approved.
Answered November 8, 2026 · source page: /drug/zepbound
What does the FTC lawsuit against Hims & Hers allege?
The FTC, Utah and Los Angeles County sued Hims & Hers in federal court in San Francisco on July 29, 2026, alleging it charged and enrolled most consumers without a provider consultation, did not clearly disclose monthly refills, made online cancellation hard and shared health data with advertising platforms. An amended complaint filed November 10, 2026 added Arizona, Florida, Nebraska, Ohio and Wisconsin as co-plaintiffs. These are allegations, not findings. Hims moved to dismiss on October 22, 2026, and its November 9 quarterly report gave a January 14, 2027 hearing date. No ruling had been filed; the FTC lists the case as pending.
Answered November 21, 2026 · source page: /blog/hims-hers-ftc-lawsuit-glp1-2026
Can you trust online reviews of GLP-1 telehealth programs?
Star ratings for GLP-1 telehealth programs are a weak signal on their own, because the FTC's consumer-review rule, in effect since October 21, 2024, exists to stop fake, bought, insider and suppressed reviews, and the FTC's December 2025 order against NextMed involved fake reviews and gift cards for changing negative ones. A better test is what you can check: a printed all-in price, a named pharmacy you can look up, a named medical group, and written cancellation and refund terms. Affiliate review sites, including this one, should disclose that they earn commissions.
Answered November 8, 2026 · source page: /blog/can-you-trust-glp1-telehealth-reviews
Frequently asked questions
Which GLP-1 telehealth program does GLPOneReview rank first?
As of November 21, 2026, NexLife is GLPOneReview's editorial pick and also ranks first on our computed transparency index, meeting 5 of 6 published disclosure checks, with compounded tirzepatide at $129 a month month to month or $115 a month on a 12-month plan, prices dated November 6, 2026. The editorial pick is a selection, not a score: we withdrew the fixed 94/100 v4.1 score because four of its seven categories could not be scored from verified evidence for every program. Price check, November 20, 2026: Eden Health charges the same $129 month to month and Mondae $126. Compounded drugs are not FDA-approved.
How much does NexLife cost per month?
As of November 6, 2026, NexLife's own plan pages list compounded tirzepatide at $129 a month month to month and $125, $119 or $115 a month on 3-, 6- or 12-month plans, and compounded semaglutide at $109 month to month and $105, $99 or $95 a month on those plans, the same at every dose. We re-read them unchanged on November 20, 2026. NexLife's FAQ says the 3-, 6- and 12-month plans are paid upfront at checkout, so a 12-month plan is $1,380 for tirzepatide or $1,140 for semaglutide. There is no membership fee, and lab work is not listed as included.
Is NexLife a legitimate GLP-1 telehealth provider?
NexLife is a U.S. cash-pay telehealth program that, on pages we read through November 21, 2026, names its medical director (Adam Kennah, M.D.), names state-licensed 503A compounding pharmacies (three on its plan pages, two in its FAQ), and publishes prices, cancellation terms and a refund policy before checkout. FDA sent NexLife warning letter 730096 on June 8, 2026 about website claims; no close-out letter had been posted. Its compounded drugs are not FDA-approved, and GLPOneReview is affiliate-supported, so check the pharmacy licenses yourself before you pay.
What are NexLife's cancellation and refund terms?
NexLife cancellations take effect 30 days after NexLife receives the request, so you may receive and pay for one more shipment, according to the plan pages, FAQ and cancellation policy we read on November 20 and 21, 2026, and NexLife's medical team can waive that notice only for serious medical reasons. The pages differ on how to cancel: the plan pages list call, text, email or a portal message, while the FAQ and policy say email care@nexlife.us. Unshipped months of a 3-, 6- or 12-month plan are refunded; shipped medication is final. Its separate guarantee refunds program fees only, under conditions.
How does NexLife's price compare with other tracked programs?
Price check, first-party reads of November 20, 2026, month to month: NexLife charges $129 for compounded tirzepatide and $109 for semaglutide, Eden Health charges $129 and $99, Mondae $126 and $87, and Collective $85.58 and $75.58 including its yearly membership. On a 12-month plan NexLife is $115 and $95 a month, the same at every dose, with no membership. WellMedr ($69 and $39, sale), SnagRx ($119 and $69, sale), Embody ($119 and $69 on prepaid years, read October 15) and NextMeds ($49, "starting at") print sale, prepaid or unstated-term figures. NexLife prices are dated November 6, 2026.
Does Hims & Hers still offer compounded GLP-1s?
Hims & Hers says it now offers compounded GLP-1s only "on a limited scale", according to the quarterly report it filed with the SEC on November 9, 2026, and on November 6, 2026 it committed, in a joint release with Eli Lilly, not to offer compounded copies of Lilly's GLP-1 medicines. Its weight-loss page, read for this site on November 21, 2026, listed only brand medications, from $149 a month for the Wegovy pill or Foundayo to $299 for Zepbound, plus a required membership of $39 for the first month, then $149 a month. Check current terms on hims.com before you enroll.
Is compounded tirzepatide or semaglutide FDA-approved?
No: compounded tirzepatide and compounded semaglutide are not FDA-approved, and FDA does not review them for safety, effectiveness or quality before they are sold, according to FDA's page on unapproved GLP-1 drugs, current as of October 1, 2026, which we read on November 21, 2026. They are made with the drug in Zepbound or Wegovy but are not the same product. A licensed 503A pharmacy may compound them for an individual prescription. FDA proposed in April 2026 to keep both off the 503B bulks list; no final decision was found as of November 20, 2026.
How much does Zepbound cost without insurance?
Without insurance, Lilly's self-pay offer for the Zepbound KwikPen is $299 for a month of 2.5 mg, $399 for 5 mg and $449 for 7.5 mg to 15 mg when each refill is bought within 45 days, otherwise $499 at 7.5 mg and $699 at 10 to 15 mg, per Lilly's terms read October 15, 2026. A month means 28 days, the savings card allows 11 fills a calendar year, and the savings end December 31, 2026. Eleven fills at $449 come to $4,939, and because each fill covers 28 days they last 308 days, not a full year. Compounded tirzepatide is cheaper but is not FDA-approved.
What does the FTC lawsuit against Hims & Hers allege?
The FTC, Utah and Los Angeles County sued Hims & Hers in federal court in San Francisco on July 29, 2026, alleging it charged and enrolled most consumers without a provider consultation, did not clearly disclose monthly refills, made online cancellation hard and shared health data with advertising platforms. An amended complaint filed November 10, 2026 added Arizona, Florida, Nebraska, Ohio and Wisconsin as co-plaintiffs. These are allegations, not findings. Hims moved to dismiss on October 22, 2026, and its November 9 quarterly report gave a January 14, 2027 hearing date. No ruling had been filed; the FTC lists the case as pending.
Can you trust online reviews of GLP-1 telehealth programs?
Star ratings for GLP-1 telehealth programs are a weak signal on their own, because the FTC's consumer-review rule, in effect since October 21, 2024, exists to stop fake, bought, insider and suppressed reviews, and the FTC's December 2025 order against NextMed involved fake reviews and gift cards for changing negative ones. A better test is what you can check: a printed all-in price, a named pharmacy you can look up, a named medical group, and written cancellation and refund terms. Affiliate review sites, including this one, should disclose that they earn commissions.